Here’s Why Venture Capitalists Like Juno

Aug. 7 (Bloomberg) -- Juno Therapeutics Scientific Co-Founder Michael Jensen and Second Avenue Partners Co-Founder Nick Hanauer discuss the Juno’s favor with venture capitalists. They speak on “Market Makers.” (Source: Bloomberg)

Most Recent Videos

Low Interest Rates Driving Real Estate Demand: Tonckens
31:30 - Jan. 29 -- Unibail-Rodamco CFO Jaap Tonckens discusses the health of the European real estate sector with Bloomberg’s Mark Barton, Anna Edwards and Manus Cranny on “Countdown.”
  • Could Russia Be Looking at More Sanctions?
  • Greek Banks Are Pretty Strong: Nouy
  • Germany Seen Under Pressure to `Cut Greece Some Slack'